The Germinal Center and T cell help in Three Phases of Clearance of Plasmodium
生发中心和 T 细胞帮助清除疟原虫的三个阶段
基本信息
- 批准号:10291407
- 负责人:
- 金额:$ 17.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-11-01 至 2022-07-15
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAffinityAnimal ModelAnimalsAntibodiesAntibody AffinityAntibody FormationAntibody ResponseAppearanceB-LymphocytesBiological AssayBiological MarkersBlocking AntibodiesBloodCD4 Positive T LymphocytesCell CommunicationCellsCessation of lifeChildChronicDataDevelopmentErythrocytesGenerationsGeneticGoalsGrowthHelper-Inducer T-LymphocyteHumanHybridsImmune responseImmune systemImmunityImmunoglobulin Class SwitchingInfectionInfection ControlInterferon Type IIKnockout MiceKnowledgeMalariaMalaria VaccinesMediatingModelingMusParasite ControlParasitemiaParasitesPathologicPathologyPersonsPhasePhenotypePlasma CellsPlasmablastPlasmodiumPlayProductionReactionRegulationReporterRiskRoleSorting - Cell MovementStructureStructure of germinal center of lymph nodeT-LymphocyteT-Lymphocyte SubsetsTestingTh1 CellsWorkcell typecytokineefficacy evaluationexperimental studyimprovedin vivomalaria infectionmouse modelnovelnovel vaccinesresponsetranslational potentialvaccine developmentvaccine strategyvaccine-induced immunity
项目摘要
ABSTRACT
Despite improvements in infection control, one child dies every minute from malaria, which is caused by
infection by Plasmodium parasites. Children develop immunity to malaria slowly after multiple exposures, and
lose immunity in the absence of continuous exposure. A lack of critical knowledge about the antibody response
that controls this infection hinders vaccine development. Early IFN-γ from Th1 cells limits early parasite growth
and correlates with protection. CD4 T helper cells (Th) also promote parasite-specific antibody, which we have
proposed is primarily required for full parasite clearance, which takes over a month. IL-21 promotes B cell
responses and is also required for clearance of Plasmodium. Splenic germinal centers optimize B:T cell
interactions that promote isotype switching and affinity maturation of antibodies, and long-lived plasma cell
generation. However, the appearance of GCs is delayed until late in infection by the Th1 response. This slow
response may explain the delay of development of immunity observed in the field. However, there is a
significant extrafollicular antibody response that is faster, and actually corresponds with dramatic control of the
parasite. In addition, our preliminary data showing that knockout mice lacking germinal centers (GC) control
infection, led us to develop a working model of protection consisting of three phases. First, Th1 cytokines limit
parasite growth; next, GC-independent factors control the parasite to low, but chronic levels without pathology;
when finally, GCs play a role in complete clearance. Yet, the types of Th cells required, and the dominant
mechanisms of antibody-mediated parasite killing are not yet clear, especially in the control phase. The
role of IL-21 in an extrafollicular response has not been sufficiently studied to understand the mechanisms or
importance. Therefore, we hypothesize that GC-independent mechanisms driven by IL-21 make a significant
contribution to the control of Plasmodium infection. To test this, in Aim 1, we will compare the contribution of
GCs and IL-21 for control of parasite. We will determine the importance of GC-driven antibody changes by
using novel mouse models separately deficient in isotype switching and affinity maturation. There are also
important unanswered questions about the type of Th cells that help B cells make antibody in malaria infection.
We and others have recently discovered that the effector T helper cell response to mouse and human malaria
is composed largely of a hybrid IFN-γ+ IL-21+ Th1/Tfh cell type that has all the hallmarks of both Th1 and Tfh.
While IFN-γ was recently shown to inhibit GC formation, the role of hybrid IFN-γ+/IL-21+ T cells' contribution to
antibody production in vivo, and their role in protection from parasitemia and pathology in malaria, have not
been tested. Therefore, In Aim 2 we will evaluate the efficacy of hybrid IFN-γ+/IL-21+ Th1/Tfh in protection, by
sorting them using cytokine reporter mice, and determine the phases of infection where IL-21 is critical.
Understanding the mechanisms of both the control phase and final clearance is critical because control of
parasite corresponds with termination of malaria pathology and may suggest novel vaccine strategies.
抽象的
尽管感染控制有所改善,但一个孩子每分钟都死于疟疾,这是由
寄生虫感染。多次暴露后,儿童对疟疾的免疫力缓慢,并且
在没有连续暴露的情况下失去免疫力。缺乏有关抗体反应的批判性知识
控制这种感染会阻碍疫苗的发育。来自Th1细胞的早期IFN-γ限制了早期寄生虫生长
并与保护相关。 CD4 T辅助细胞(Th)还促进了寄生虫特异性抗体,我们已经具有
提议的主要寄生虫清除主要是需要一个月的时间。 IL-21促进B细胞
响应,也是清除疟原虫所必需的。脾生发中心优化B:T细胞
促进抗体和长期血浆细胞的同种型切换和亲和力成熟的相互作用
一代。但是,TH1反应在感染后延迟GC的出现延迟。这很慢
反应可能解释了在现场观察到的免疫发育的延迟。但是,有一个
更快的速度外抗体反应,实际上与对
寄生虫。此外,我们的初步数据表明缺乏生发中心(GC)控制的敲除小鼠
感染,使我们开发了一个由三个阶段组成的保护模型。首先,Th1细胞因子极限
寄生虫生长;接下来,与GC无关的因素将寄生虫控制为低但没有病理的慢性水平。
最后,GCS在完全清除中发挥了作用。然而,所需的TH细胞类型和主要
抗体介导的寄生虫杀死的机制尚不清楚,尤其是在控制阶段。
IL-21在外面反应中的作用尚不完全研究,以了解机制或
重要性。因此,我们假设IL-21驱动的与GC无关的机制使得
对控制疟原虫感染的贡献。为了测试这一点,在AIM 1中,我们将比较
GCS和IL-21用于控制寄生虫。我们将确定通过GC驱动的抗体变化的重要性
使用新颖的小鼠模型分别缺乏同种型切换和亲和力成熟。也有
关于帮助B细胞在疟疾感染中导致抗体的TH细胞类型的重要问题。
我们和其他人最近发现,效应助理细胞对小鼠和人类疟疾的反应
主要由具有TH1和TFH的所有标志的杂种IFN-γ+ IL-21+ TH1/TFH细胞类型组成。
虽然最近显示IFN-γ抑制GC的形成,但混合IFN-γ+/IL-21+ T细胞对
体内抗体的产生及其在保护免受寄生虫病和疟疾病理学中的作用,尚未
经过测试。因此,在AIM 2中,我们将评估混合IFN-γ+/IL-21+ TH1/TFH在保护中的效率,
使用细胞因子报道小鼠对它们进行排序,并确定IL-21至关重要的感染阶段。
了解控制阶段和最终清除的机制至关重要,因为控制
寄生虫与疟疾病理学的终止相对应,并可能表明新型的疫苗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robin Stephens其他文献
Robin Stephens的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robin Stephens', 18)}}的其他基金
Mechanisms of Neuroinflammation in Experimental Cerebal Malaria
实验性脑型疟疾的神经炎症机制
- 批准号:
10674093 - 财政年份:2022
- 资助金额:
$ 17.05万 - 项目类别:
Mechanisms of Neuroinflammation in Experimental Cerebal Malaria
实验性脑型疟疾的神经炎症机制
- 批准号:
10237349 - 财政年份:2018
- 资助金额:
$ 17.05万 - 项目类别:
Mechanisms of Neuroinflammation in Experimental Cerebal Malaria
实验性脑型疟疾的神经炎症机制
- 批准号:
10000179 - 财政年份:2018
- 资助金额:
$ 17.05万 - 项目类别:
Mechanisms of Neuroinflammation in Experimental Cerebal Malaria
实验性脑型疟疾的神经炎症机制
- 批准号:
9762232 - 财政年份:2018
- 资助金额:
$ 17.05万 - 项目类别:
The Germinal Center and T cell help in Three Phases of Clearance of Plasmodium
生发中心和 T 细胞帮助清除疟原虫的三个阶段
- 批准号:
10053293 - 财政年份:2017
- 资助金额:
$ 17.05万 - 项目类别:
The Germinal Center and T cell help in Three Phases of Clearance of Plasmodium
生发中心和 T 细胞帮助清除疟原虫的三个阶段
- 批准号:
10664202 - 财政年份:2017
- 资助金额:
$ 17.05万 - 项目类别:
Maintenance vs Programming in Th1 Memory Cell Development in P. Chabaudi Malaria
P. Chabaudi 疟疾中 Th1 记忆细胞发育的维护与编程
- 批准号:
8904855 - 财政年份:2011
- 资助金额:
$ 17.05万 - 项目类别:
Maintenance vs Programming in Th1 Memory Cell Development in P. Chabaudi Malaria
P. Chabaudi 疟疾中 Th1 记忆细胞发育的维护与编程
- 批准号:
8857363 - 财政年份:2011
- 资助金额:
$ 17.05万 - 项目类别:
Maintenance vs Programming in Th1 Memory Cell Development in P. Chabaudi Malaria
P. Chabaudi 疟疾中 Th1 记忆细胞发育的维护与编程
- 批准号:
8187472 - 财政年份:2011
- 资助金额:
$ 17.05万 - 项目类别:
Maintenance vs Programming in Th1 Memory Cell Development in P. Chabaudi Malaria
P. Chabaudi 疟疾中 Th1 记忆细胞发育的维护与编程
- 批准号:
8479208 - 财政年份:2011
- 资助金额:
$ 17.05万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Tissue-engineered Aged B Cell Immune Organoid to Study Antibody Secreting Cell Differentiation Trajectory
组织工程老化 B 细胞免疫类器官用于研究抗体分泌细胞分化轨迹
- 批准号:
10804886 - 财政年份:2023
- 资助金额:
$ 17.05万 - 项目类别:
2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland
2023 年国际疫苗协会 (ISV) 年会,10 月 22 日至 25 日,瑞士洛桑
- 批准号:
10754840 - 财政年份:2023
- 资助金额:
$ 17.05万 - 项目类别:
Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs
基于 mRNA 的自我扩增疫苗可引发 VRC01 级 bnAb
- 批准号:
10589641 - 财政年份:2023
- 资助金额:
$ 17.05万 - 项目类别:
"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
“延长剂量”免疫增强对下一代疫苗的体液免疫
- 批准号:
10638732 - 财政年份:2023
- 资助金额:
$ 17.05万 - 项目类别:
Rational design and efficacy testing of vaccines against HCV
HCV疫苗的合理设计和功效测试
- 批准号:
10618256 - 财政年份:2022
- 资助金额:
$ 17.05万 - 项目类别: